Olpruva logo

FDA APPROVED FOR THE

TREATMENT OF UREA CYCLE DISORDERS

For US healthcare professionals only

FDA APPROVED

FOR THE TREATMENT OF

UREA CYCLE DISORDERS

Sign Up
  • Prescribing Information
  • Important Safety Information
  • Request a Call/Email
  • Prescription Enrollment Form
  • Patient/Caregiver Site
  • About OLPRUVA
  • Controlling Ammonia
  • Dosing and Administration
    • Dosing
    • Administration
  • Prescribing OLPRUVA
  • Support and Resources
  • Sign Up
  • Prescribing Information
  • Important Safety Information
  • Request a Call/Email
  • Prescription Enrollment Form
  • Patient/Caregiver Site

Taking OLPRUVA

  • About OLPRUVA
  • Controlling Ammonia
  • Dosing and Administration
    • Dosing
    • Administration
  • Prescribing OLPRUVA
  • Support and Resources
  • Sign Up
  • Prescribing Information
  • Important Safety Information
  • Request a Call/Email
  • Prescription Enrollment Form
  • Patient/Caregiver Site
  • About OLPRUVA
  • Controlling Ammonia
  • Dosing and Administration
    • Dosing
    • Administration
  • Prescribing OLPRUVA
  • Support and Resources
  • Sign Up
  • Prescribing Information
  • Important Safety Information
  • Request a Call/Email
  • Prescription Enrollment Form
  • Patient/Caregiver Site
  • Terms and Conditions
  • Privacy Policy
  • Contact Us

The information provided in this website is intended for US residents.

© 2023 Acer Therapeutics Inc.
All Rights Reserved. June 2023
PRC-OLP-22-023-2

Acer

You are leaving the OLPRUVA healthcare
professional website and going to the OLPRUVA
patient/caregiver website.

Do you wish to continue?

Click YES to leave this site, or click NO to return
to the OLPRUVA healthcare professional site.

YES

You are leaving OLPRUVAHCP.com and going
to a third-party website.

Do you wish to continue?

Click YES to leave this site, or click NO to return
to OLPRUVAHCP.com.

YES